Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4.

Saved in:
Bibliographic Details
Title: Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4.
Authors: Rodríguez-Otero P; Cancer Center Clínica Universidad de Navarra, Cima, CIBERONC, Pamplona, Spain., Sidana S; Stanford University School of Medicine, Stanford, CA, USA., Kouwenhoven M; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Schecter JM; Johnson & Johnson, Raritan, NJ, USA., Lendvai N; Johnson & Johnson, Raritan, NJ, USA., De Braganca KC; Johnson & Johnson, Raritan, NJ, USA., Slaughter A; Johnson & Johnson, Zug, Switzerland., Lonardi C; Johnson & Johnson, Buenos Aires, Argentina., Vlummens P; Johnson & Johnson, Beerse, Belgium., Varsos H; Johnson & Johnson, Raritan, NJ, USA., Corsale C; Johnson & Johnson, Raritan, NJ, USA., Madduri D; Johnson & Johnson, Raritan, NJ, USA., Zhao H; Johnson & Johnson, Beerse, Belgium., Li K; Johnson & Johnson, Spring House, PA, USA., Lee E; Johnson & Johnson, Titusville, NJ, USA., Marquez L; Johnson & Johnson, Raritan, NJ, USA., Zhao M; IQVIA, Shanghai, China., Yeh TM; Johnson & Johnson, Raritan, NJ, USA., Chen D; Johnson & Johnson, Shanghai, China., Plaks V; Johnson & Johnson, Spring House, PA, USA., Montes de Oca R; Johnson & Johnson, Spring House, PA, USA., Florendo E; Legend Biotech USA Inc., Somerset, NJ, USA., Patel N; Legend Biotech USA Inc., Somerset, NJ, USA., Akram M; Legend Biotech USA Inc., Somerset, NJ, USA., Koneru M; Legend Biotech USA Inc., Somerset, NJ, USA., Santomasso BD; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gállego Perez-Larraya J; Neurology Department, Clínica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain., van de Donk NW; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. n.vandedonk@amsterdamumc.nl.
Source: Blood cancer journal [Blood Cancer J] 2025 Nov 26; Vol. 15 (1), pp. 209. Date of Electronic Publication: 2025 Nov 26.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2044-5385
DOI:10.1038/s41408-025-01410-w